-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, GC1fRWgdzsUxO7gz443I/HedaH4ZLVJX29U3ti1ufBZENOhnuQydAK/PRy/Si3OJ dOLNvbQF6mrPyhBFIk77bg== 0001047469-04-036324.txt : 20050720 0001047469-04-036324.hdr.sgml : 20050720 20041207144235 ACCESSION NUMBER: 0001047469-04-036324 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20041207 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NITROMED INC CENTRAL INDEX KEY: 0000927829 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 223159793 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 12 OAK PARK DR CITY: BEDFORD STATE: MA ZIP: 01730 BUSINESS PHONE: 7816859700 MAIL ADDRESS: STREET 1: 12 OAK PARK DR CITY: BEDFORD STATE: MA ZIP: 01730 CORRESP 1 filename1.txt NITROMED, INC. 125 SPRING STREET LEXINGTON, MASSACHUSETTS 02421 --------------------------------- December 7, 2004 BY EDGAR SUBMISSION Securities and Exchange Commission Judiciary Plaza 450 Fifth Street, N.W. Washington, D.C. 20549 Attention: Albert C. Lee Re: NitroMed, Inc. Registration Statement on Form S-1 Commission File No. 333-120280 Request for Acceleration Dear Mr. Lee: In accordance with Rule 461 under the Securities Act of 1933, as amended, NitroMed, Inc. (the "Company") hereby requests acceleration of the effective date of the above-referenced Registration Statement on Form S-1 (the "Filing") so that it may become effective at 3:00 p.m. Eastern time, on Tuesday, December 7, 2004, or as soon thereafter as may be practicable. In addition, the Company hereby acknowledges as follows: o should the Securities and Exchange Commission (the "Commission") or the staff (the "Staff"), acting pursuant to delegated authority, declare the Filing effective, it does not foreclose the Commission from taking any action with respect to the Filing; o the action of the Commission or the Staff, acting pursuant to delegated authority, in declaring the Filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the Filing; and o the Company may not assert this action as a defense in any proceeding initiated by the Commission or any person under the federal securities law of the United States. Very truly yours, /s/ James Ham III James Ham III VICE PRESIDENT OF FINANCE -----END PRIVACY-ENHANCED MESSAGE-----